Emory Transplant Center has been recognized as the first transplant center in the nation to receive the Patient-Centered Specialty Practice Level 3 recognition from the National Committee for Quality Assurance (NCQA). A level 3...
Diagnosed with Cystic Fibrosis as a baby, Kendra Adderhold struggled to have a normal childhood. Her mother brought her to the Emory Cystic Fibrosis Center for treatment and, until adulthood, things were rather stable....
Made possible by the HIV Organ Policy Equity (HOPE) Act, Emory Transplant Center has performed its first HIV-positive kidney transplant from an HIV-positive deceased donor. Not only was this Emory’s first HIV to HIV...
Simone Whitehead was an active 30-year-old, running half marathons and chasing around her 2-year-old son. In April 2016, she began to feel ill, and she slowly started getting worse. Tests revealed that her liver...
Emory Transplant Center will soon begin enrolling patients into a new clinical trial that will test an FDA-approved drug in HIV positive patients receiving a kidney transplant. The research study will evaluate the safety...
The National Institutes of Minority Health and Health Disparities has awarded $2.6 million over five years to the Emory Transplant Center and six other transplant centers and organizations in the Southeastern Kidney Transplant Coalition....
Emory is nationally renowned for using a multidisciplinary approach to treat cancer. But many may not know there is a multidisciplinary team right here at the Emory Transplant Center with the mission of improving...
A study of kidney transplant recipients has shown for the first time that the drug belatacept (Nulojix), which controls the immune system and prevents graft rejection, has a better record of patient and organ...